Hamburg Outlines Planned Reforms Of FDA Criminal Investigations Office
This article was originally published in The Gray Sheet
Executive Summary
FDA Commissioner Margaret Hamburg outlined reforms planned for the agency's Office of Criminal Investigations, including new criteria for selecting misdemeanor prosecution cases against responsible corporate officials